ストックスクリーナーアプリを入手
91.51
1.88%
1.69
プレマーケット:
91.15
-0.36
-0.39%
Astrazeneca PLC (AZN) 最新ニュース
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? - Insider Monkey
AstraZeneca: A Rare Compound Growth Opportunity In Biopharma (AZN) - Seeking Alpha
Aug Ideas: Will Precidian ETFs Trust AstraZeneca PLC stock maintain strong growthJuly 2025 Sector Moves & Smart Allocation Stock Reports - BỘ NỘI VỤ
Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks - Benzinga
AstraZeneca price target raised to $105 from $95 at TD Cowen on growth outlook - Investing.com UK
AstraZeneca (AZN) Begins Phase 3 Trial of Enhertu for Ovarian Ca - GuruFocus
Quantbot Technologies LP Reduces Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Hsbc Holdings PLC - MarketBeat
Cerity Partners LLC Increases Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca (LSE:AZN): Assessing Valuation After a Strong Year-to-Date Share Price Rally - Yahoo Finance
AstraZeneca PLC (NASDAQ:AZN) Nasdaq Futures Science-Driven Growth - Kalkine Media
AstraZeneca PLC ADR Rises Monday, Outperforms Market - 富途牛牛
Pillar Biosciences and AstraZeneca expand liquid biopsy access partnership to China - marketscreener.com
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China - marketscreener.com
AstraZeneca is top pharma tip for 2026, with GSK left trailing - Proactive Investors
How Are AstraZeneca’s Scientific Initiatives Influencing Its FTSE 100 Standing? - Kalkine Media
AstraZeneca (AZN) Price Target Raised by JPMorgan - GuruFocus
First Trust Advisors LP Acquires 217,595 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Bought by Invesco Ltd. - MarketBeat
1832 Asset Management L.P. Acquires 18,543 Shares of AstraZeneca PLC $AZN - MarketBeat
Surprises Report: Is AstraZeneca PLC ZEG stock resilient in recession scenariosLong Setup & High Accuracy Investment Signals - BỘ NỘI VỤ
AstraZeneca PLC $AZN Shares Sold by Capital Fund Management S.A. - MarketBeat
AstraZeneca: An Insight Into The Growth Potential Of Imfinzi - Smartkarma
SCS Capital Management LLC Purchases 142,331 Shares of AstraZeneca PLC $AZN - MarketBeat
Marshall Wace LLP Buys 623,902 Shares of AstraZeneca PLC $AZN - MarketBeat
Guggenheim Capital LLC Has $13.58 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
UK stocks gain ahead of key US inflation data; AstraZeneca rises - marketscreener.com
Is AstraZeneca PLC (Common Stock) (ZEGA) stock a buy on weaknessWeekly Profit Summary & Fast Gain Stock Tips - Newser
Epoch Investment Partners Inc. Trims Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca selects Salesforce’s Agentforce for global HCP engagement By Investing.com - Investing.com Nigeria
Is Precidian ETFs Trust AstraZeneca PLC stock a top dividend aristocrat candidateTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Why Precidian ETFs Trust AstraZeneca PLC stock benefits from AI revolutionQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
Has AstraZeneca’s Strong 30% Rally Left Further Upside in 2025? - Yahoo Finance
Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement - Yahoo Finance
AstraZeneca Stake Adjustment by Capital Group - TipRanks
AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report - Sahm
ASTRAZENECA : Bernstein remains its Buy rating - marketscreener.com
FDA Streamlines Clinical Study Requirements, Impacting AstraZene - GuruFocus
AstraZeneca (AZN) Could Benefit from FDA's Shift to Single Study Approval - GuruFocus
REGAstraZeneca PLCHolding(s) in Company - TradingView
AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH - marketscreener.com
Neurimmune expands collaboration with AstraZeneca to develop and commercialize Fibril Depleter NI009 for AL Amyloidosis - marketscreener.com
AstraZeneca news live: price tests Ichimoku Kijun support — bullish momentum meets consolidation risks - Traders Union
M&T Bank Corp Has $15.30 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Bernstein Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Raises Target Price to $245.46 - 富途牛牛
AstraZeneca PLC Advances Hematology and Cell Therapy Ambition with Largest-Ever Presence at ASH - marketscreener.com
AstraZeneca (AZN) Set to Showcase Hematology Innovations at ASH 2025 - GuruFocus
New York State Common Retirement Fund Has $13.74 Million Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca to showcase hematology advances at ASH annual meeting By Investing.com - Investing.com UK
Arrowstreet Capital Limited Partnership Cuts Position in AstraZeneca PLC $AZN - MarketBeat
Guggenheim Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Raises Target Price to $206.76 - 富途牛牛
AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026 - Benzinga
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
How AstraZeneca PLC (ZEG) stock correlates with oil marketsTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
AstraZeneca (AZN) Named One of BofA's Top 25 Stocks for 2026 - Finviz
AstraZeneca stock price target raised to GBP155 by Morgan Stanley - Investing.com UK
AstraZeneca Remains Top Pick at Morgan StanleyBN - MarketScreener
AstraZeneca (AZN) Named One of BofA’s Top 25 Stocks for 2026 - MSN
UK Government to Consult Executives from AstraZeneca, GSK on New Drug Pricing Regime - MarketScreener
COPD Market to Expand Significantly by 2034, States DelveInsight Report | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZeneca - Barchart.com
UK Government Partners with AstraZeneca (AZN) for Drug Pricing S - GuruFocus
Pangaea and AstraZeneca forge multimodal AI partnership - Medical Device Network
AstraZeneca, GSK to Join UK Working Group on New Drug-Pricing Framework - MarketScreener
AstraZeneca (AZN) Gains FDA Priority Review for Hypertension Dru - GuruFocus
FDA grants priority review for AstraZeneca’s hypertension drug baxdrostat By Investing.com - Investing.com UK
AstraZeneca Moves Ahead of Mineralys With Fast Baxdrostat Review - Citeline News & Insights
Mackenzie Financial Corp Purchases 118,653 Shares of AstraZeneca PLC $AZN - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $5.76 Million Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
大文字化:
|
ボリューム (24 時間):